
Keywords: مهار کننده آراماتاز; aromatase inhibitor; distant metastasis; endocrine therapy; primary mucinous carcinoma of the skin; ER; estrogen receptor; FDG; [18F]-fluorodeoxy-D-glucose; PET-CT; positron emission tomography-computed tomography; PgR; progesterone receptor; PMCS; prim